IMAX Corp (IMAX) insider Mark Welton reports 25,000-share sale under 10b5-1 plan

Rhea-AI Filing Summary

IMAX Corp officer Mark Welton, President IMAX Global Theatres, reported a sale of 25,000 common shares on 12/15/2025 at $39.28 per share. The sale was made pursuant to a Rule 10b5-1 Plan dated September 15, 2025.

After this transaction, he beneficially owns 128,323 common shares, and his remaining restricted share unit balance is 70,609.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 2 txns

Insider WELTON MARK

Role President IMAX Global Theatres

Sold 25,000 shs ($982K)

Type	Security	Shares	Price	Value
Sale	common shares	25,000	$39.28	$982K
holding	common shares (opening balance)	--	--	--

Holdings After Transaction: common shares — 128,323 shares (Direct); common shares (opening balance) — 153,323 shares (Direct)

Footnotes (2)

1. F1. This sale is pursuant to a 10b5-1 Plan dated September 15, 2025.
2. F2. Mr. Welton's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 128,323, respectively.

FAQ

What insider transaction did IMAX (IMAX) report for Mark Welton?

IMAX reported that Mark Welton, President IMAX Global Theatres, sold 25,000 common shares of IMAX Corp on 12/15/2025 at $39.28 per share.

Was the IMAX (IMAX) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states that the sale of 25,000 shares was made pursuant to a 10b5-1 Plan dated September 15, 2025, and the related 10b5-1 checkbox is referenced.

How many IMAX (IMAX) shares does Mark Welton own after this transaction?

Following the reported sale, Mark Welton beneficially owns 128,323 common shares of IMAX Corp. He also has 70,609 restricted share units remaining.

What is Mark Welton’s role at IMAX (IMAX)?

Mark Welton is an officer of IMAX Corp, serving as President IMAX Global Theatres, as disclosed in the filing.

Is this IMAX (IMAX) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as filed by one reporting person, covering the holdings and transactions of Mark Welton only.

Who signed the IMAX (IMAX) Form 4 for Mark Welton?

The Form 4 was signed by /s/ Kenneth I. Weissman as attorney-in-fact for Mark Welton on 12/15/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/15/2025 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELTON MARK

(Last) (First) (Middle)

2525 SPEAKMAN DRIVE

C/O IMAX CORPORATION

(Street)

MISSISSAUGA A6 L5K 1B1

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President IMAX Global Theatres

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								153,323	D
common shares	12/15/2025		S		25,000(1)	D	$39.28	128,323(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale is pursuant to a 10b5-1 Plan dated September 15, 2025.

2. Mr. Welton's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 128,323, respectively.

Remarks:

	/s/ Kenneth I. Weissman (attorney-in-fact for Mark Welton)	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.